2014
DOI: 10.1016/j.jfo.2013.11.012
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of transepithelial corneal collagen crosslinking with epithelium-off crosslinking in progressive keratoconus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
38
1
2

Year Published

2015
2015
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(42 citation statements)
references
References 23 publications
1
38
1
2
Order By: Relevance
“…[8][9][10][11][12][13][14][15][16][17][18][19][20] The only comparative study in adults comparing the topography indices of a transepithelial CXL group with those of an epithelium-off CXL group 13 reported an increase of 1.00 D or more in the apical K value in 65% of patients 12 months after transepithelial CXL; however, the report is not in English. Magli et al 16 compared transepithelial CXL with epithelium-off CXL in a pediatric population; the 2 treatments showed similar effectiveness.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…[8][9][10][11][12][13][14][15][16][17][18][19][20] The only comparative study in adults comparing the topography indices of a transepithelial CXL group with those of an epithelium-off CXL group 13 reported an increase of 1.00 D or more in the apical K value in 65% of patients 12 months after transepithelial CXL; however, the report is not in English. Magli et al 16 compared transepithelial CXL with epithelium-off CXL in a pediatric population; the 2 treatments showed similar effectiveness.…”
Section: Discussionmentioning
confidence: 99%
“…In 5 studies including a total of 141 eyes, topographic parameters worsened. 9,10,[12][13][14] In the remaining 8 studies involving 223 eyes, the topographic parameters improved or stabilized. 8,11,[15][16][17][18][19][20] In 5 studies including a total of 244 eyes, the follow-up was 12 months, 8,15,[17][18][19] and in 3 studies including a total of 86 patients it was 18 months.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…6,[25][26][27][28] Twelve-month results from one recently published randomized controlled trial 6 concluded that transepithelial CXL using Ricrolin TE (Sooft Italia S.p.A.) was not effective at stabilizing corneal shape compared with epithelium-off treatment. For iontophoresis, up to 15-month followup data have been published, with reported cessation of disease progression and improvements in keratometric and visual parameters.…”
Section: Discussionmentioning
confidence: 99%
“…Despite these chemical enhancers, results in clinical studies with transepithelial riboflavin preparations have been equivocal: Some studies report similar efficacy to epithelium-off CXL, 14,15 but most report inferior results. [10][11][12][16][17][18] Iontophoresis, in which an electrical gradient is used to drive negatively charged riboflavin molecules across the intact epithelium, may further enhance riboflavin penetration in transepithelial CXL. Laboratory studies of iontophoresis have been encouraging, demonstrating enhanced transepithelial riboflavin penetration and improvement of corneal biomechanics.…”
Section: Methodsmentioning
confidence: 99%